Chester County News and Community Website
NEWTOWN, PA — Traws Pharma Inc. (NASDAQ: TRAW) has deferred a planned Phase 2a human influenza challenge study of its lead antiviral candidate tivoxavir marboxil after receiving unfavorable feedback from …
Traws Delays Influenza Study After UK Regulatory Setback Read More
SOUTHAMPTON, PA — Environmental Tectonics Corp. (OTCID: ETCC) reported fiscal 2026 net income of $3.0 million, down 77% from the prior year, as a large tax-related benefit recorded in fiscal …
ETC Earnings Fall as Tax Shift Masks Third Straight Profit Read More
PERKASIE, PA — Gina Rubel, chief executive officer and general counsel of Furia Rubel Communications, has been named to the 2026 Philadelphia Titan 100, joining a group of executives recognized …
Gina Rubel Earns Philadelphia Titan 100 Recognition Read More
TREVOSE, PA — Hand & Stone Massage and Facial Spa is expanding its investment in workforce development through a new scholarship initiative aimed at attracting more students to massage therapy …
Hand & Stone Expands Workforce Pipeline With Wellness Scholarships Read More
PHILADELPHIA, PA — Urban Outfitters Inc. (NASDAQ: URBN) plans to invest at least $150 million in Pennsylvania, expanding operations in Philadelphia and Bucks County while creating a minimum of 1,050 …
Urban Outfitters Expands Pennsylvania Footprint With $150M Investment, 1,050 New Jobs Read More
LANGHORNE, PA — NEXGEL Inc. (NASDAQ: NXGL) will present to investors at the Planet MicroCap Conference in Las Vegas later this month as the hydrogel products manufacturer seeks to increase …
NEXGEL Expands Investor Outreach With MicroCap Conference Appearance Read More
NEW HOPE, PA — Orchestra BioMed Holdings Inc. (Nasdaq: OBIO) has granted stock options covering 85,500 shares to five newly hired employees, using an inducement plan designed to support recruitment …
Orchestra BioMed Grants Equity Awards to New Employees Read More
DOYLESTOWN, PA — Aprea Therapeutics reported early signs of anti-tumor activity from its ongoing Phase 1 trial of experimental cancer therapy APR-1051, with partial responses observed in patients with advanced …
Aprea Reports Early Tumor Responses in Phase 1 APR-1051 Study Read More DOYLESTOWN, PA — Aprea Therapeutics (Nasdaq: APRE) is expanding enrollment in a Phase 1 study of its experimental cancer drug APR-1051 after early clinical data showed tumor responses and disease …
Aprea Expands Cancer Trial After Early Tumor Responses Read More
SOUTHAMPTON, PA — Quaint Oak Bank is expanding financial support for public libraries in eastern Pennsylvania through a series of community partnerships aimed at strengthening educational programming, environmental initiatives, and …
Quaint Oak Expands Library Funding Through Centennial Initiative Read More